Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Tak (Rotterdam, Netherlands), C. Moor (Rotterdam, Netherlands), C. Owusuaa (Rotterdam, Netherlands), C. Van Der Rijt (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands). The value of the surprise question to predict mortality in idiopathic pulmonary fibrosis. 1800

Member's Comments

No comment yet.

Related content which might interest you: The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Source: Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 Year: 2018 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis? Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 HRCT score to control and evaluate the prognosis in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias? Source: Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020 Year: 2021 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016 Year: 2017 Hyaluroman syntehase-2 over expression has impact in the evolution and on the prognosis of idiopathic pulmonary fibrosis patients Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue Source: Eur Respir Rev, 28 (153) 190044; 10.1183/16000617.0044-2019 Year: 2019 Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Pulmoanry hypertension is a negative prognostic factot of long term survival in patients with idiopathic pulmonary fibrosis after lung transplantation Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Does interferon-γ improve pulmonary function in idiopathic pulmonary fibrosis? Source: Eur Respir J 2003 Dec 01;22(6):906-911 Year: 2003 Towards a better diagnosis of idiopathic pulmonary fibrosis Source: Eur Respir Rev 2011; 20: 108-113 Year: 2011 Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging Source: Eur Respir J 2015; 46: 604-606 Year: 2015 Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017